Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report.
Mohammed A, Dashwood RH, Dickinson S, Disis ML, Jaffee EM, Johnson BD, Khleif SN, Pollak MN, Schlom J, Shoemaker RH, Stanton SE, Wondrak GT, You M, Zhu H, Miller MS. Mohammed A, et al. Among authors: stanton se. J Cancer Prev. 2021 Dec 30;26(4):309-317. doi: 10.15430/JCP.2021.26.4.309. J Cancer Prev. 2021. PMID: 35047458 Free PMC article.
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates.
Liao JB, Gwin WR, Urban RR, Hitchcock-Bernhardt KM, Coveler AL, Higgins DM, Childs JS, Shakalia HN, Swensen RE, Stanton SE, Tinker AV, Wahl TA, Ancheta RG, McGonigle KF, Dai JY, Disis ML, Goff BA. Liao JB, et al. Among authors: stanton se. J Immunother Cancer. 2021 Sep;9(9):e003122. doi: 10.1136/jitc-2021-003122. J Immunother Cancer. 2021. PMID: 34531249 Free PMC article.
Immunotherapy in breast cancer: An introduction.
Disis ML, Stanton SE. Disis ML, et al. Among authors: stanton se. Breast. 2018 Feb;37:196-199. doi: 10.1016/j.breast.2017.01.013. Epub 2017 Feb 3. Breast. 2018. PMID: 28162837
23 results